RCKT - Rocket Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$5.00
DETAILS
HIGH:
$5.00
LOW:
$5.00
MEDIAN:
$5.00
CONSENSUS:
$5.00
UPSIDE:
68.92%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 11.0 | 0 | 0 | 0 | 0 | 1.1 | 0.4 | 0.3 | 0.2 | 0.2 | 0.0 | 0 | 0 | 0 |
| Gross Profit | (11.0) | 0 | 0 | 0 | 0 | (1.1) | (0.4) | (0.3) | (0.2) | (0.2) | (0.0) | 0 | 0 | 0 |
| Operating Expenses | ||||||||||||||
| R&D Expenses | 142.0 | 171.2 | 186.3 | 165.6 | 125.5 | 106.4 | 58.6 | 53.3 | 14.2 | 32.0 | 12.6 | 5.6 | 5.3 | 3.5 |
| SG&A Expenses | 86.5 | 102.0 | 73.3 | 58.8 | 41.8 | 27.9 | 17.5 | 17.9 | 12.5 | 9.9 | 7.8 | 2.1 | 1.3 | 2.3 |
| Other Expenses | (11.0) | 0 | 0 | 0 | 0 | 0 | (0.2) | (0.2) | 0 | 0 | 0 | 0 | 0.0 | 0.0 |
| Operating Expenses | 217.5 | 273.2 | 259.7 | 224.3 | 167.2 | 134.9 | 75.9 | 71.0 | 26.7 | 41.9 | 20.4 | 7.7 | 6.7 | 5.8 |
| Operating Income | ||||||||||||||
| Operating Income | (228.5) | (273.2) | (259.7) | (224.3) | (167.2) | (136.0) | (76.2) | (71.2) | (26.7) | (41.9) | (20.4) | (7.7) | (6.7) | (5.8) |
| Interest Expense | 1.9 | 1.9 | 1.9 | 1.9 | 5.9 | 7.5 | 4.8 | 5.2 | 3.6 | 1.4 | 1.2 | 1.0 | 0.9 | 0.2 |
| Interest Income | 10.6 | 18.2 | 15.9 | 3.9 | 3.1 | 2.1 | 3.4 | 1.7 | 0.8 | 0.4 | 0.1 | 0 | 0 | 0 |
| Profitability | ||||||||||||||
| EBITDA | (210.2) | (247.5) | (236.6) | (213.7) | (157.8) | (131.6) | (71.1) | (71.2) | (26.7) | (41.3) | (20.3) | (7.7) | (6.7) | (5.8) |
| EBIT | (221.2) | (256.9) | (243.7) | (220.0) | (163.2) | (132.7) | (71.6) | (68.7) | (20.2) | (41.4) | (66.8) | (11.8) | (6.7) | (5.8) |
| Income Before Tax | (223.1) | (258.7) | (245.6) | (221.9) | (169.1) | (139.7) | (77.3) | (74.5) | (29.5) | (42.9) | (68.0) | (9.5) | (7.6) | (6.1) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 7.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (223.1) | (258.7) | (245.6) | (221.9) | (169.1) | (146.7) | (83.2) | (74.5) | (29.5) | (42.9) | (68.0) | (9.5) | (7.6) | (6.1) |
| Per Share Data | ||||||||||||||
| EPS (Basic) | -2.01 | -2.73 | -2.92 | -3.26 | -2.68 | -2.52 | -1.70 | -1.89 | -4.36 | -6.41 | -10.29 | -4.53 | -3.62 | -2.88 |
| EPS (Diluted) | -2.01 | -2.73 | -2.92 | -3.26 | -2.68 | -2.52 | -1.70 | -1.89 | -4.36 | -6.41 | -14.85 | -4.53 | -3.62 | -2.88 |
| Shares Outstanding | 111.1 | 94.8 | 84.0 | 68.1 | 63.2 | 55.4 | 49.0 | 39.4 | 6.8 | 6.7 | 6.6 | 2.1 | 2.1 | 2.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 77.6 | 163.6 | 55.9 | 140.5 | 232.7 | 297.1 | 185.4 | 111.4 | 78.7 | 29.8 |
| Short-Term Investments | 111.4 | 208.7 | 317.3 | 215.9 | 156.0 | 185.6 | 118.7 | 94.4 | 21.3 | 96.7 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 3.8 | 5.8 | 5.0 | 7.7 | 0 | 0 | 0 | 3.4 | 0 | 0 |
| Total Current Assets | 192.7 | 378.2 | 378.2 | 364.1 | 392.1 | 487.3 | 307.8 | 209.1 | 101.0 | 128.3 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 71.6 | 83.3 | 87.6 | 77.6 | 72.3 | 70.6 | 31.3 | 2.0 | 0.6 | 1.1 |
| Goodwill | 39.2 | 39.2 | 39.2 | 39.2 | 30.8 | 30.8 | 30.8 | 30.8 | 0 | 0 |
| Intangible Assets | 25.1 | 25.1 | 25.1 | 25.7 | 0 | 0 | 0.2 | 0 | 0 | 0 |
| Long-Term Investments | 1.3 | 0 | 34.3 | 43.3 | 0 | 0 | 1.5 | 7.4 | 0.2 | 0 |
| Other Non-Current Assets | 0.5 | 1.9 | 1.9 | 1.9 | 1.8 | 3.6 | 2.0 | 1.4 | (0.0) | 0.2 |
| Total Non-Current Assets | 137.7 | 149.5 | 188.1 | 187.7 | 105.0 | 103.5 | 64.4 | 42.2 | 0.7 | 1.3 |
| Total Assets | 330.4 | 527.7 | 566.3 | 551.8 | 497.0 | 590.8 | 372.1 | 251.3 | 101.8 | 129.6 |
| Current Liabilities | ||||||||||
| Account Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 1.6 |
| Short-Term Debt | 2.9 | 0 | 0 | 0 | 0 | 4.9 | 1.0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 |
| Other Current Liabilities | 27.3 | 11.9 | 9.9 | 10.0 | 4.5 | 2.0 | 12.7 | 12.9 | 0.6 | 3.0 |
| Total Current Liabilities | 30.2 | 40.7 | 48.5 | 39.2 | 22.2 | 32.6 | 18.3 | 15.4 | 4.1 | 7.2 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 35.1 | 45.0 | 41.4 | 49.5 | 49.0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.1 | 1.1 | 2.9 | 2.6 | 0.1 | 0.1 | 0.0 | 0.5 | 0.4 | 0.3 |
| Total Non-Current Liabilities | 23.0 | 23.8 | 25.3 | 23.0 | 20.1 | 54.7 | 46.5 | 41.9 | 49.9 | 49.3 |
| Total Liabilities | 53.2 | 64.5 | 73.8 | 62.1 | 42.3 | 87.3 | 64.8 | 57.3 | 54.0 | 56.5 |
| Stockholders' Equity | ||||||||||
| Common Stock | 1.1 | 1.1 | 0.9 | 0.8 | 0.6 | 0.6 | 0.5 | 0.5 | 0.1 | 0.3 |
| Retained Earnings | (1,441.2) | (1,218.1) | (959.4) | (713.8) | (491.9) | (322.8) | (183.1) | (105.9) | (268.4) | (238.9) |
| Accumulated Other Comprehensive Income | (0.0) | 0.1 | 0.3 | (0.4) | (0.2) | (0.0) | 0.0 | (0.1) | (0.0) | (0.1) |
| Total Stockholders' Equity | 277.2 | 463.2 | 492.6 | 489.7 | 454.7 | 503.5 | 307.3 | 194.0 | 47.8 | 73.2 |
| Total Liabilities & Equity | 330.4 | 527.7 | 566.3 | 551.8 | 497.0 | 590.8 | 372.1 | 251.3 | 101.8 | 129.6 |
| Debt Metrics | ||||||||||
| Total Debt | 24.9 | 25.5 | 25.0 | 22.9 | 22.6 | 61.7 | 47.4 | 41.4 | 49.5 | 49.0 |
| Net Debt | (52.7) | (138.1) | (30.9) | (117.7) | (210.1) | (235.4) | (137.9) | (69.9) | (29.2) | 19.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (223.1) | (258.7) | (245.6) | (221.9) | (169.1) | (139.7) | (77.3) | (74.5) | (29.5) | (42.9) |
| Depreciation & Amortization | 11.0 | 9.4 | 7.1 | 6.3 | 5.4 | 1.1 | 0.4 | 0.3 | 0.2 | 0.2 |
| Stock-Based Compensation | 37.1 | 43.9 | 39.4 | 31.0 | 29.2 | 18.6 | 13.4 | 13.6 | 4.0 | 2.9 |
| Change in Working Capital | (8.3) | 1.9 | 13.5 | 6.1 | (3.4) | 15.0 | (3.7) | 4.4 | (2.0) | 2.1 |
| Other Non-Cash Items | (6.7) | (6.2) | (9.3) | 0.4 | 13.5 | 29.3 | 3.6 | 2.9 | 0.5 | 0.2 |
| Operating Cash Flow | (190.0) | (209.7) | (194.9) | (178.1) | (121.2) | (74.6) | (64.7) | (53.8) | (26.1) | (37.3) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.4) | (5.9) | (16.5) | (8.6) | (7.7) | (29.1) | (23.3) | (1.5) | (0.1) | (0.5) |
| Acquisitions | 0 | 0 | 0 | 42.7 | 0.1 | 8.5 | 0.0 | 76.3 | 0 | 0 |
| Purchases of Investments | (276.6) | (245.9) | (390.9) | (376.3) | (245.9) | (209.3) | (184.3) | (141.1) | (27.2) | (122.3) |
| Sales/Maturities of Investments | 380.8 | 383.5 | 309.3 | 272.9 | 272.4 | 141.8 | 168.6 | 61.3 | 102.3 | 56.7 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (0.1) | (8.5) | (0.0) | (0.4) | 0 | 0 |
| Investing Cash Flow | 103.8 | 131.7 | (98.1) | (69.3) | 18.9 | (96.6) | (39.0) | (5.3) | 75.0 | (66.1) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0.0 | 0 | 0.1 | 0.2 | 0.2 | 5.6 | 0 | 0 | 0 | 48.7 |
| Stock Repurchased | 0 | 0 | 0 | (0.0) | 0 | (0.1) | 0 | (0.7) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.1 | 0 | (0.1) | (0.2) | (0.2) | (3.9) | (0.3) | 0.1 | 0.0 | 0.3 |
| Financing Cash Flow | 0.1 | 185.7 | 208.4 | 155.3 | 37.7 | 283.0 | 177.8 | 153.5 | 0.0 | 0.0 |
| Cash Position | ||||||||||
| Net Change in Cash | (86.1) | 107.7 | (84.6) | (92.2) | (64.6) | 111.8 | 74.1 | 94.4 | 48.9 | (50.2) |
| Cash at Beginning | 165.0 | 57.3 | 141.9 | 234.0 | 298.7 | 186.9 | 112.8 | 18.3 | 29.8 | 80.0 |
| Cash at End | 78.9 | 165.0 | 57.3 | 141.9 | 234.0 | 298.7 | 186.9 | 112.8 | 78.7 | 29.8 |
| Free Cash Flow | (190.5) | (215.6) | (211.4) | (186.8) | (128.9) | (103.7) | (87.9) | (55.2) | (26.2) | (37.8) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (11.0) | 0 | 0 | 0 | 0 | (1.1) | (0.4) | (0.3) | (0.2) | (0.2) | (0.0) | 0 | 0 | 0 |
| Operating Income | (228.5) | (273.2) | (259.7) | (224.3) | (167.2) | (136.0) | (76.2) | (71.2) | (26.7) | (41.9) | (20.4) | (7.7) | (6.7) | (5.8) |
| Net Income | (223.1) | (258.7) | (245.6) | (221.9) | (169.1) | (146.7) | (83.2) | (74.5) | (29.5) | (42.9) | (68.0) | (9.5) | (7.6) | (6.1) |
| EPS (Diluted) | -2.01 | -2.73 | -2.92 | -3.26 | -2.68 | -2.52 | -1.70 | -1.89 | -4.36 | -6.41 | -14.85 | -4.53 | -3.62 | -2.88 |
| Balance Sheet | ||||||||||||||
| Cash & Equivalents | 77.6 | 163.6 | 55.9 | 140.5 | 232.7 | 297.1 | 185.4 | 111.4 | 78.7 | 29.8 | ||||
| Total Assets | 330.4 | 527.7 | 566.3 | 551.8 | 497.0 | 590.8 | 372.1 | 251.3 | 101.8 | 129.6 | ||||
| Total Debt | 24.9 | 25.5 | 25.0 | 22.9 | 22.6 | 61.7 | 47.4 | 41.4 | 49.5 | 49.0 | ||||
| Stockholders' Equity | 277.2 | 463.2 | 492.6 | 489.7 | 454.7 | 503.5 | 307.3 | 194.0 | 47.8 | 73.2 | ||||
| Cash Flow | ||||||||||||||
| Operating Cash Flow | (190.0) | (209.7) | (194.9) | (178.1) | (121.2) | (74.6) | (64.7) | (53.8) | (26.1) | (37.3) | ||||
| Capital Expenditure | (0.4) | (5.9) | (16.5) | (8.6) | (7.7) | (29.1) | (23.3) | (1.5) | (0.1) | (0.5) | ||||
| Free Cash Flow | (190.5) | (215.6) | (211.4) | (186.8) | (128.9) | (103.7) | (87.9) | (55.2) | (26.2) | (37.8) | ||||